激光联合复方血栓通胶囊治疗CSC的疗效
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

2012年佛山市科技局科研立项(No.20120862)


Compound Xueshuantong capsule joint laser treating central serous chorioretinopathy
Author:
Affiliation:

Fund Project:

Foshan Municipal Science and Technology Bureau of science nesearch Project In 2012(No.20120862)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨复方血栓通胶囊联合激光治疗中心性浆液性脉络膜视网膜病变(central serous chorioretinopathy,CSC)疗效。

    方法:选取38例40眼CSC患者,随机分为治疗组和对照组两组,每组20眼,治疗组采用激光联合复方血栓通胶囊治疗, 对照组采用激光治疗,比较两组在治疗效果和复发率方面的差异。

    结果:治疗组与对照组比较,治疗后1wk视力显著提高,两组间比较差异有显著性(P<0.05); 治疗1mo后黄斑区水肿明显吸收, 总有效率治疗组优于对照组,两组比较差异有统计学意义(P<0.05)。

    结论:激光联合复方血栓通胶囊治疗CSC,能够快速减轻症状,提高视力,减少复发,起到良好临床效果。

    Abstract:

    AIM: To study the clinical effects of Compound Xueshuantong capsule combined with laser in treating central serous chorioretinopathy(CSC).

    METHODS: Totally 38 patients(40 eyes)who suffered CSC were divided into two groups randomly. Laser combined with Compound Xueshuantong capsule for treatment group(n=20)and laser was used in controlled group(n=20)respectively. The curative effect and recurrent rate were compared in two groups.

    RESULTS: After 1 week treatment, the sight was increased significantly in treatment group(P<0.05). After 1 month treatment, the absorption of edema was significantly in treatment group(P<0.05).

    CONCLUSION: Compound Xueshuantong capsule combined with laser can relieve symptoms quickly and reduce recurrence, which was a good method for CSC.

    参考文献
    相似文献
    引证文献
引用本文

叶静,杨雪艳,曾胜.激光联合复方血栓通胶囊治疗CSC的疗效.国际眼科杂志, 2013,13(6):1160-1162.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2012-11-06
  • 最后修改日期:2013-05-27
  • 录用日期:
  • 在线发布日期: 2013-06-03
  • 出版日期:
文章二维码